Papers
7
Total Citations
662
H-Index
5
About
Dr. Yiping Mou is a pioneering figure in pancreatic surgery, with a career dedicated to advancing minimally invasive techniques for complex pancreatic diseases. His primary research focuses on the safety, efficacy, and oncologic outcomes of robotic and laparoscopic approaches for pancreatic resections, including distal pancreatectomy and pancreatoduodenectomy. Dr. Mou’s most impactful contribution is his leadership in developing the Miami International Evidence-Based Guidelines on Minimally Invasive Pancreas Resection (2019), a landmark work cited over 478 times that has standardized global practice. He has also conducted influential meta-analyses comparing robotic versus laparoscopic distal pancreatectomy, demonstrating improved perioperative outcomes with the robotic approach. His work extends to designing the PORTAL trial, a multicenter phase III randomized controlled trial comparing robotic and open pancreatoduodenectomy, which promises to shape future surgical standards. Additionally, Dr. Mou has contributed to Chinese expert consensus guidelines for minimally invasive radical surgery for pancreatic cancer and pancreatic neuroendocrine tumors, ensuring high-quality care in his home country. With over 660 citations across his most-cited works, Dr. Mou’s research has profoundly impacted surgical practice, offering patients safer, more effective options for pancreatic disease management.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7